HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.

AbstractPURPOSE:
Design and synthesis of a tumor responsive nanoparticle-based system for imaging and treatment of various cancers.
METHODS:
Manganese oxide nanoparticles (Mn3O4 NPs) were synthesized and modified with LHRH targeting peptide or anti-melanoma antibodies (cancer targeting moieties) and a MMP2 cleavable peptide (a possible chemotactic factor). Nanostructured lipid carriers (NLCs) were used to entrap the BRAF inhibitor, vemurafenib, and enhance cytotoxicity of the drug. Size distribution, stability, drug entrapment, cytotoxicity and genotoxicity of synthesized nanoparticles were studied in vitro. Enhancement of MRI signal by nanoparticles and their body distribution were examined in vivo on mouse models of melanoma, ovarian and lung cancers.
RESULTS:
Uniform, stable cancer-targeted nanoparticles (PEGylated water-soluble Mn3O4 NPs and NLCs) were synthesized. No signs of cyto-,genotoxicity and DNA damage were detected for nanoparticles that do not contain an anticancer drug. Entrapment of vemurafenib into nanoparticles significantly enhanced drug toxicity in cancer cells with targeted V600E mutation. The developed nanoparticles containing LHRH and MMP2 peptides showed preferential accumulation in primary and metastatic tumors increasing the MRI signal in mice with melanoma, lung and ovarian cancers.
CONCLUSIONS:
The proposed nanoparticle-based systems provide the foundation for building an integrated MRI diagnostic and therapeutic approach for various types of cancer.
AuthorsRonak Savla, Olga B Garbuzenko, Suzie Chen, Lorna Rodriguez-Rodriguez, Tamara Minko
JournalPharmaceutical research (Pharm Res) Vol. 31 Issue 12 Pg. 3487-502 (Dec 2014) ISSN: 1573-904X [Electronic] United States
PMID24919932 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Biocompatible Materials
  • Contrast Media
  • Drug Carriers
  • Indoles
  • Manganese Compounds
  • Oxides
  • Sulfonamides
  • Vemurafenib
  • manganese oxide
Topics
  • Animals
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Biocompatible Materials
  • Cell Survival (drug effects)
  • Contrast Media (administration & dosage, chemistry)
  • Drug Carriers
  • Drug Delivery Systems
  • Female
  • Humans
  • Indoles (administration & dosage, therapeutic use)
  • Lung Neoplasms (diagnosis, drug therapy)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Manganese Compounds (chemistry)
  • Melanoma (diagnosis, drug therapy)
  • Mice
  • Nanoparticles (chemistry)
  • Ovarian Neoplasms (diagnosis, drug therapy)
  • Oxides (chemistry)
  • Sulfonamides (administration & dosage, therapeutic use)
  • Tissue Distribution
  • Vemurafenib

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: